News

The first patients just enrolled in a trial testing the arthritis drug Actemra against the coronavirus. Results are expected in early summer.

At least six coronavirus patients have been enrolled in a late-stage clinical trial testing the arthritis drug Actemra as a coronavirus treatment. Mark Eisner, Genentech’s global head of immunology, infectious disease, and ophthalmology clinical development, told Business Insider on Monday the study enrolled the first patients on Friday in the […]
The first patients just enrolled in a trial testing the arthritis drug Actemra against the coronavirus. Results are expected in early summer.